Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study. Issue 11 (29th August 2022)
- Record Type:
- Journal Article
- Title:
- Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study. Issue 11 (29th August 2022)
- Main Title:
- Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study
- Authors:
- Golfrè Andreasi, Nico
Cilia, Roberto
Romito, Luigi Michele
Bonvegna, Salvatore
Straccia, Giulia
Elia, Antonio Emanuele
Novelli, Alessio
Messina, Giuseppe
Tringali, Giovanni
Levi, Vincenzo
Devigili, Grazia
Rinaldo, Sara
Gasparini, Valentina
Grisoli, Marina
Stanziano, Mario
Ghielmetti, Francesco
Prioni, Sara
Bocchi, Elisa
Amami, Paolo
Piacentini, Sylvie Hélène Marie Jeanne
Ciceri, Elisa Francesca Maria
Bruzzone, Maria Grazia
Eleopra, Roberto - Abstract:
- ABSTRACT: Background: Magnetic resonance–guided focused ultrasound (MRgFUS) thalamotomy is a safe and effective procedure for drug‐resistant tremor in Parkinson's disease (PD). Objective: The aim of this study was to demonstrate that MRgFUS ventralis intermedius thalamotomy in early‐stage tremor‐dominant PD may prevent an increase in dopaminergic medication 6 months after treatment compared with matched PD control subjects on standard medical therapy. Methods: We prospectively enrolled patients with early‐stage PD who underwent MRgFUS ventralis intermedius thalamotomy (PD‐FUS) and patients treated with oral dopaminergic therapy (PD‐ODT) with a 1:2 ratio. We collected demographic and clinical data at baseline and 6 and 12 months after thalamotomy. Results: We included 10 patients in the PD‐FUS group and 20 patients in the PD‐ODT group. We found a significant increase in total levodopa equivalent daily dose and levodopa plus monoamine oxidase B inhibitors dose in the PD‐ODT group 6 months after thalamotomy. Conclusions: In early‐stage tremor‐dominant PD, MRgFUS thalamotomy may be useful to reduce tremor and avoid the need to increase dopaminergic medications. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
- Is Part Of:
- Movement disorders. Volume 37:Issue 11(2022)
- Journal:
- Movement disorders
- Issue:
- Volume 37:Issue 11(2022)
- Issue Display:
- Volume 37, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 37
- Issue:
- 11
- Issue Sort Value:
- 2022-0037-0011-0000
- Page Start:
- 2289
- Page End:
- 2295
- Publication Date:
- 2022-08-29
- Subjects:
- Parkinson's disease -- tremor -- thalamotomy -- VIM -- MRgFUS
Movement disorders -- Periodicals
610 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8257 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/mds.29200 ↗
- Languages:
- English
- ISSNs:
- 0885-3185
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5980.317200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24692.xml